Pharma companies to hike the cost of over 350 drugs in 2023. Pfizer, AstraZeneca, GlaxoSmithKline, Bristol Myers Squibb, and Sanofi are among several drugmakers set to raise prices on more than 350 products from January, according to an analysis conducted by healthcare research firm 3 Axis Advisors. The price hikes are in response to the soaring cost of living* and continued supply chain constraints leading to higher manufacturing costs.
Join the more than 4 thousand ambitious entrepreneurs & investors hellbent on making our mark on the world. Subscribe today to become a Market Mover. Make better business & investment decisions with our daily curation service.
This post is for subscribers only
Sign up now to read the post and get access to the full library of posts for subscribers only.